During the past decade, Aultman Health Foundation conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 99 clinical trials were completed, i.e. on average, 103.1% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 57 clinical trials were completed. i.e. 190% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aultman Health Foundation" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Boston Scientific Corporation" with 10 trials sponsored and "Aultman Health Foundation" with 10 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aultman Health Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Genentech, Inc." with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "Canadian Cancer Trials Group" with 6 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Aultman Health Foundation" are "Breast Cancer" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (8 trials), "Fallopian Tube Mucinous Adenocarcinoma" (8 trials) and "Fallopian Tube Transitional Cell Carcinoma" (8 trials). Many other conditions were trialed in "Aultman Health Foundation" in a lesser frequency.

Most popular intervention types in "Aultman Health Foundation" are "Drug" (144 trials), "Other" (104 trials), "Biological" (65 trials), "Procedure" (33 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Quality-of-Life Assessment" (41 trials), "Paclitaxel" (34 trials), "Carboplatin" (28 trials) and "Bevacizumab" (24 trials). Other intervention names were less common.

The vast majority of trials in "Aultman Health Foundation" are 138 trials for "All" genders, 60 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Aultman Health Foundation". undefined are not yet recruiting, 30 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Aultman Health Foundation, 3 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Aultman Health Foundation, 0 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 21 trials that are defined as “Not Applicable".

Aultman Health Foundation has several departments that took part in Clinical trials: "Aultman Cancer Center at Aultman Hospital" - 86 trials, "Aultman Hospital - Timken Family Cancer Center" - 3 trials